PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Azithromycin - Bacterial infection
PAD Profile : Azithromycin - Bacterial infection
Keywords :
antibiotic, antibacterial, macrolide
Brand Names Include :
Zithromax
Traffic Light Status
Status 1 of 1.
Status :
Green
Important
Formulations :
- Capsules
- Oral suspension
Important Information :
Restricted Use - for use when indicated by local trust antimicrobial guidelines, NICE condensed summary table of antimicrobial guidance or specialist microbiology recommendation.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Guidelines
No guidelines returned.
Other Drugs
- Cefaclor
- Fusidic acid
- Amoxicillin
- Benzylpenicillin sodium (Penicillin G)
- Cefalexin
- Cefotaxime sodium
- Ceftriaxone sodium
- Ciprofloxacin
- Clarithromycin
- Co-trimoxazole(Trimethoprim/sulfamethoxazole)
- Doxycycline hyclate
- Erythromycin
- Flucloxacillin sodium
- Levofloxacin
- Metronidazole
- Nitrofurantoin
- Phenoxymethylpenicillin (Penicillin V)
- Trimethoprim
- Amikacin
- Aztreonam
- Cefepime
- Cefixime
- Ceftazidime pentahydrate
- Cefuroxime sodium
- Chloramphenicol
- Dalbavancin hydrochloride
- Dapsone
- Daptomycin
- Demeclocycline hydrochloride
- Ertapenem sodium
- Gentamicin sulfate
- Imipenem with cilastatin
- Meropenem
- Moxifloxacin
- Norfloxacin
- Ofloxacin
- Piperacillin sodium/tazobactam sodium
- Rifabutin
- Sodium fusidate
- Streptomycin
- Sulfadiazine
- Teicoplanin
- Temocillin sodium
- Tigecycline
- Tinidazole
- Vancomycin hydrochloride
Other Indications
No indications returned.
Additional Documents
No additional documents returned.
Committee Recommendations
Date
Committee Name
Narrative
01 May 2024
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.
Associated BNF Codes
05. Infections
05.01.05. Macrolides